VIVIAN CRAFT: Open Payments
NPI 1780443887 · EDGEWATER, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$368 in 16 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $346 · 2025 $368
Food & beverage: $368
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 3 | $86 |
| Otsuka America Pharmaceutical, Inc. | 3 | $78 |
| ABBVIE INC. | 3 | $58 |
| Alkermes, Inc. | 2 | $51 |
| Teva Pharmaceuticals USA, Inc. | 2 | $32 |
| Neurocrine BioSciences, Inc. | 1 | $23 |
| Lundbeck LLC | 1 | $22 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
Products named: HETLIOZ, ABILIFY MAINTENA, VRAYLAR, ARISTADA, AUSTEDO XR, INGREZZA, ABILIFY ASIMTUFII, CAPLYTA.
Industry payments across MD — which companies pay providers there.
